Table 2:
LORR – ISO Emerge/Induce | LORR – HAL Emerge/Induce | |||||||
---|---|---|---|---|---|---|---|---|
Control | Astrocyte-specific Ndufs4(KO) | Control | Astrocyte-specific Ndufs4(KO) | |||||
Induction | Emergence | Induction | Emergence | Induction | Emergence | Induction | Emergence | |
3 weeks | 1.02±0.10 | 1.0±0.07 | 0.97±0.06 | 0.62±0.12* | 1.03±0.05 | 1.0±0.04 | 0.99±0.08 | 0.64±0.09 * |
7 weeks | 0.92±0.07 | 0.89±0.06 | 0.98±0.05 | 0.68±0.08* | 0.98±0.08 | 0.94±0.04 | 0.93±0.13 | 0.55±0.07* |
In each cell, bold numbers show the ratios of EC50s for emergence and induction for isoflurane or halothane, for control mice or astrocyte specific Ndufs4(KO), at 3 weeks and 7 weeks post 4-hydroxytamoxifen injections. The endpoint used is loss of righting reflex. The lower set of numbers in each cell are the measured values for the EC50s (emergence) and the EC50s (induction), respectively. p-values compare the KO ratio to the corresponding control ratio.
indicates p< 0.005. N=6 for controls, N≥6 for the astrocytic Ndufs4(KO).